EICHOR
● Active Not Recruiting
Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer
Condition: Breast Cancer · Sponsor: Eli Lilly and Company
About this study
The purpose of this study is to evaluate the safety and efficacy of the study drug abemaciclib in participants with high risk, node positive, early stage, hormone receptor positive (HR+), human epidermal receptor 2 negative (HER2-), breast cancer.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (619)
| University of Alabama Birmingham | Birmingham, Alabama, United States | — |
| Providence Alaska Medical Center | Anchorage, Alaska, United States | — |
| Banner MD Anderson Cancer Center | Gilbert, Arizona, United States | — |
| Arizona Oncology Associates, P.C. - HOPE | Goodyear, Arizona, United States | — |
| St. Joseph's Hospital and Medical Center | Phoenix, Arizona, United States | — |
| Mayo Clinic Hospital | Phoenix, Arizona, United States | — |
| The University of Arizona Cancer Center | Tucson, Arizona, United States | — |
| Yuma Regional Cancer Center | Yuma, Arizona, United States | — |
| St. Bernards Medical Center | Jonesboro, Arkansas, United States | — |
| Highlands Oncology Group | Springdale, Arkansas, United States | — |
| Beverly Hills Cancer Center | Beverly Hills, California, United States | — |
| Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center | Burbank, California, United States | — |
+ 607 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03155997